These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Topical psoralen plus ultraviolet A treatment for necrobiosis lipoidica. McKenna DB; Cooper EJ; Tidman MJ Br J Dermatol; 2000 Dec; 143(6):1333-5. PubMed ID: 11122054 [No Abstract] [Full Text] [Related]
4. Long-term results of topical PUVA in necrobiosis lipoidica. Narbutt J; Torzecka JD; Sysa-Jedrzejowska A; Zalewska A Clin Exp Dermatol; 2006 Jan; 31(1):65-7. PubMed ID: 16309486 [TBL] [Abstract][Full Text] [Related]
5. Treatment of necrobiosis lipoidica with topical psoralen plus ultraviolet A. De Rie MA; Sommer A; Hoekzema R; Neumann HA Br J Dermatol; 2002 Oct; 147(4):743-7. PubMed ID: 12366422 [TBL] [Abstract][Full Text] [Related]
6. A prospective open study of topical psoralen-UV-A therapy for Necrobiosis lipoidica. Patel GK; Mills CM Arch Dermatol; 2001 Dec; 137(12):1658-60. PubMed ID: 11735728 [No Abstract] [Full Text] [Related]
7. Long-term successful healing of ulcerated necrobiosis lipoidica after topical therapy with becaplermin. Tauveron V; Rosen A; Khashoggi M; Abdallah-Lotf M; Machet L Clin Exp Dermatol; 2013 Oct; 38(7):745-7. PubMed ID: 23962308 [TBL] [Abstract][Full Text] [Related]
8. Update: Treatment of necrobiosis lipoidica. Peckruhn M; Tittelbach J; Elsner P J Dtsch Dermatol Ges; 2017 Feb; 15(2):151-157. PubMed ID: 28214312 [TBL] [Abstract][Full Text] [Related]
13. [Ulcerated necrobiosis lipoidica associated with insulin-dependent diabetes mellitus. Beneficial effect of corticosteroid therapy by oral administration]. Hocqueloux L; Gautier JF; Lebbe C; Jellal M; Vexiau P; Morel P; Cathelineau G Presse Med; 1996 Jan 6-13; 25(1):25-7. PubMed ID: 8728888 [TBL] [Abstract][Full Text] [Related]
14. Persistent ulcerated necrobiosis lipoidica responding to treatment with cyclosporin. Darvay A; Acland KM; Russell-Jones R Br J Dermatol; 1999 Oct; 141(4):725-7. PubMed ID: 10583126 [TBL] [Abstract][Full Text] [Related]
15. [Necrobiosis lipoidica. Report of 4 cases and review of the literature]. Fourati M; Marrak H; Fenniche S; Zakraoui H; Zghal M; Khayat O; Ben Ayed M; Mokhtar I Tunis Med; 2003 Jun; 81(6):428-31. PubMed ID: 14534951 [TBL] [Abstract][Full Text] [Related]
16. [Successful therapy of ulcerated necrobiosis lipoidica non diabeticorum with cyclosporine A]. Aslan E; Körber A; Grabbe S; Dissemond J Hautarzt; 2007 Aug; 58(8):684-8. PubMed ID: 17429587 [TBL] [Abstract][Full Text] [Related]
17. Treatment of ulcerated necrobiosis lipoidica with intravenous immunoglobulin and methylprednisolone. Batchelor JM; Todd PM J Drugs Dermatol; 2012 Feb; 11(2):256-9. PubMed ID: 22270213 [TBL] [Abstract][Full Text] [Related]
18. Juvenile ulcerated necrobiosis lipoidica successfully treated with oral cyclosporin A. Gualdi G; Monari P; Farisoglio C; Calzavara-Pinton P G Ital Dermatol Venereol; 2013 Dec; 148(6):703-4. PubMed ID: 24442055 [No Abstract] [Full Text] [Related]
19. Ulcerated necrobiosis lipoidica treated with cyclosporin A. Stinco G; Parlangeli ME; De Francesco V; Frattasio A; Germino M; Patrone P Acta Derm Venereol; 2003; 83(2):151-3. PubMed ID: 12735655 [No Abstract] [Full Text] [Related]
20. Systemic corticosteroids for the outpatient treatment of necrobiosis lipoidica in a diabetic patient. Tan E; Patel V; Berth-Jones J J Dermatolog Treat; 2007; 18(4):246-8. PubMed ID: 17671885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]